Is there a generic version of Farxiga (dapagliflozin)?
Farxiga’s active ingredient is dapagliflozin. Whether a generic version is available depends on the specific country and on patent/exclusivity status for the dapagliflozin formulation(s) used for Farxiga.
What would a “generic Farxiga” be called?
A generic for Farxiga would be marketed under the nonproprietary name “dapagliflozin” (and may also carry different brand names depending on the manufacturer), typically as the same tablet strength and dosing regimen.
When can generics typically enter—does patent protection block them?
Generic entry is usually limited until patents and other exclusivity periods covering the product and its specific formulations expire, or until a manufacturer successfully challenges that protection.
For the most up-to-date patent and challenge landscape tied to dapagliflozin/Farxiga, see DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for Farxiga/dapagliflozin on the site).
How do I find whether generics are available where I live?
Availability is location-specific (for example, U.S., UK, EU, Canada, etc.). To check quickly, search your local pharmacy listings for:
- “dapagliflozin” (not “Farxiga”), and/or
- “dapagliflozin tablets” with the matching strength (for example, 5 mg or 10 mg, depending on what you’re prescribed).
If you tell me your country (and the Farxiga dose/strength), I can help narrow down what “generic” options you should look for and what they’re likely to be called.
Can you switch from Farxiga to dapagliflozin if a generic exists?
If a dapagliflozin generic is sold in your market, it should be pharmaceutically equivalent to Farxiga at the same dose. Still, switching can depend on your indication (type 2 diabetes vs. heart failure vs. kidney disease), kidney function, and any prescriber notes—so it’s best confirmed with your pharmacist or clinician.
Sources
- DrugPatentWatch.com – Farxiga/dapagliflozin patent/exclusivity lookup